The markets traded mixed during the midday with the Dow slipping 18 points to 15,407 as investors monitored the global economy. Nasdaq gained 8 points to 3668.
On the upside
Oppenheimer upgraded Noah Holdings (NYSE: NOAH) from a Perform rating to an Outperform rating on Friday.
Shares of Mecox Lane (Nasdaq: MCOX) surged ahead of its earnings release tomorrow after market close.
The Food and Drug Administration granted fast track designation for Galectin Therapeutics’ (Nasdaq: GALT) non-alcoholic steatohepatitis with hepatic fibrosis treatment GR-MD-O2.
On the downside
Ecotality (Nasdaq: ECTY) warned that it may file for bankruptcy protection.
Motley Fool noted that Merrimack Pharmaceuticals (Nasdaq: MACK) was one of the worst performing healthcare stocks last week.
Shares of Galena Biopharma (Nasdaq: GALE) continued falling after posting a loss for the second quarter last week.
In the broad market, advancing issues outpaced decliners by a margin of nearly 10 to 9 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 slipped 2 points to 1688.
